EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, COGT: Cogent Biosciences Inc

11 Dec 25 08:56
LAST:

38.81

CHANGE:
 0.36		OPEN:
38.89		HIGH:
38.89		ASK:
4.20		VOLUME:
748
CHG(%):
0.92		PREV:
39.17		LOW:
38.80		BID:
15.02		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
11 Dec 2538.8938.8938.8038.81748
10 Dec 2538.7739.2937.8639.172.53M
09 Dec 2539.9940.4338.1638.532.43M
08 Dec 2543.0743.7338.1040.304.88M
05 Dec 2539.4639.9438.2038.771.84M
04 Dec 2539.1639.5837.9439.312.47M
03 Dec 2539.6940.0838.5339.162.37M
02 Dec 2539.7640.2537.7538.982.99M
01 Dec 2539.4340.1438.9039.762.02M
28 Nov 2540.5841.2739.8440.221.09M

PROFILE

Name:Cogent Biosciences Inc
About:Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:275 Wyman Street, Waltham, MA, United States, 02451
Website:https://www.cogentbio.com
CUSIP:19240Q201
CIK:0001622229
ISIN:US19240Q2012
FIGI:BBG007DHZQR7

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-6.69 
Forward P/E:-7.09 
PEG Ratio:-0.71 
Price to Sales:1,320.63 
Price to Book:39.47 
Return on Assets:-0.53 
Return on Equity:-1.08 
EPS Ratio:-2.08 
Shares:139.7M 
Market Cap:5.422B 

TECHNICAL INDICATORS

MA5:39.120.8%
MA10:39.301.3%
MA20:37.633.1%
MA50:25.5252.1%
MA100:18.91105.3%
MA200:12.76204.1%
STO9:5.38 
STO14:29.41
RSI14:66.75 
WPR14:-43.53
MTM14:2.05
ROC14:0.06 
ATR:1.99 
Week High:43.7312.7%
Week Low:37.862.5%
Month High:43.7312.7%
Month Low:28.87204.1%
Year High:43.7312.7%
Year Low:3.72943.3%

RECENT SPLITS

Date Ratio
09 Nov 20201-4
27 Mar 20182-15